Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Autoimmunity Reviews|July 28, 2010
A novel tolerogenic peptide, hCDR1, for the specific treatment of systemic lupus erythematosusEdna Mozes, Amir SharabiImmunotherapy|July 20, 2010
Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseasesAmir Sharabi, Edna MozesJournal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cellsAmir Sharabi, Edna MozesJournal of Autoimmunity|July 15, 2009
Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptideAmir Sharabi, Smadar Lapter, Edna MozesJournal of Autoimmunity|June 25, 2014
Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosusZev Sthoeger, Amir Sharabi, Edna MozesJournal of Clinical Immunology|September 17, 2009
A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptideAmir Sharabi, Molly Dayan, Heidy Zinger, et al.Immunology|March 10, 2007
Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of actionAmir Sharabi, Hava Azulai, Zev M Sthoeger, et al.Journal of Neuroimmunology|December 7, 2010
Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestationsAlona Telerman, Smadar Lapter, Amir Sharabi, et al.Immunology|December 2, 2008
The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine modelsUri Sela, Amir Sharabi, Molly Dayan, et al.Clinical Immunology (Orlando, Fla.)|March 1, 2006
Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosisAmir Sharabi, Asher Haviv, Heidy Zinger, et al.Pageof 7